Pulse Biosciences (NASDAQ:PLSE – Get Free Report) will post its quarterly earnings results after the market closes on Tuesday, May 7th. Persons interested in listening to the company’s earnings conference call can do so using this link.
Pulse Biosciences (NASDAQ:PLSE – Get Free Report) last released its quarterly earnings results on Thursday, March 28th. The company reported ($0.21) earnings per share (EPS) for the quarter.
Pulse Biosciences Price Performance
Shares of NASDAQ:PLSE opened at $7.82 on Monday. The firm has a fifty day simple moving average of $8.53 and a two-hundred day simple moving average of $8.35. Pulse Biosciences has a 52 week low of $3.78 and a 52 week high of $13.62.
Pulse Biosciences Company Profile
Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.
Featured Articles
- Five stocks we like better than Pulse Biosciences
- How to Calculate Stock Profit
- Coca-Cola Stock Analysis: Key Insights and Trends
- Comparing and Trading High PE Ratio Stocks
- 3 Metal Stocks Setting Up for Double-Digit Growth
- Trading Halts Explained
- Brinker International Heats Up on Spicy Earnings Beat and Raise
Receive News & Ratings for Pulse Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulse Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
